Peregrine Capital Management’s Bio-Techne TECH Stock Holding History

Peregrine Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,076	Closed	-$999K	–	332
2022 Q3	$999K	Hold	14,076	–	–	0.03%	268
2022 Q2	$1.22M	Hold	14,076	–	–	0.04%	264
2022 Q1	$1.52M	Hold	14,076	–	–	0.04%	264
2021 Q4	$1.82M	Hold	14,076	–	–	0.04%	264
2021 Q3	$1.71M	Hold	14,076	–	–	0.04%	267
2021 Q2	$1.58M	Hold	14,076	–	–	0.03%	270
2021 Q1	$1.34M	Hold	14,076	–	–	0.02%	273
2020 Q4	$1.12M	Buy	+14,076	New	+$1.02M	0.02%	273

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Peregrine Capital Management's TECH Position: Q4 2022 in Review

Peregrine Capital Management sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 14,076 shares — an estimated $999K sold.

Peregrine Capital Management first reported a position in TECH in Q4 2020 and held it in 8 quarters. The position peaked at $1.82M in Q4 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Peregrine Capital Management reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Peregrine Capital Management sold 14,076 Bio-Techne shares in Q4 2022, an estimated $999K.
Peregrine Capital Management first reported a position in Bio-Techne in Q4 2020 and held it in 8 quarters.
Peregrine Capital Management's Bio-Techne position peaked at $1.82M in Q4 2021.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.